Interestingly, a significant reduction in tumour cell adherence was seen in the Nox1 siRNA cells following LPS treatment, indicating that Nox1 derived ROS are essential for potentiation of colon cancer cell adherence in response to LPS (Figure 7 (d)). The gene discussed is NOX1; the disease is malignant colon neoplasm.